TP53 and skin basal cell carcinoma: Additionally, a potentially oncogenic LOF mutation (OncogenicDB) in NOTCH2 (Q1061) was identified, suggesting that signaling pathways beyond the Hh and TP53 axes may contribute to BCC pathogenesis.